Blocking formation of toxic plaques implicated in type 2 diabetes

September 10, 2007

Amid growing evidence that the same abnormal clumping of proteins in Alzheimer’s disease also contributes to type-2 diabetes, scientists in New York are reporting discovery of a potent new compound that reduces formation of those so-called amyloid plaques. Their study is scheduled for the Sept. 5 issue of the Journal of the American Chemical Society.

The report cites evidence correlating increases in amyloid formation in the pancreas with increases in severity and rate of progression of type-2 diabetes, which affects almost 20 million Americans and is rapidly rising worldwide. Deposits of the abnormal protein damage and destroy insulin-producing “islet” cells in the pancreas. Researchers have been seeking potential new medicines that block formation of an abnormal, misfolded protein called islet amyloid polypeptide (IAPP), which may play a key role in the cell destruction.

In the new study, Daniel Raleigh, Andisheh Abedini and Fangli Meng found that changing a single amino acid in human IAPP’s structure transformed it from one of the most potent amyloid-forming substances into a powerful inhibitor of amyloid formation. In laboratory studies, they showed that the mutant IAPP significantly reduced the amount of amyloid formed.

n addition to opening the door for better IAPP inhibitors in type-2 diabetes, the findings provide potentially important insights into the formation and treatment of amyloid plaques in Alzheimer’s disease, Parkinson’s disease, and other conditions, the researchers say.

Source: American Chemical Society

Explore further: A new look at vitamin D challenges the current view of its benefits

Related Stories

Recommended for you

How Frankenstein saved humankind from probable extinction

October 28, 2016

Frankenstein as we know him, the grotesque monster that was created through a weird science experiment, is actually a nameless Creature created by scientist Victor Frankenstein in Mary Shelley's 1818 novel, "Frankenstein." ...

Self-sealing syringe prevents blood loss in hemophilic mice

October 28, 2016

(—For people whose blood does not clot appropriately, such as those with hemophilia, diabetes, or cancer, getting an injection or blood draw with a hypodermic needle is not a trivial matter. Because the needle ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.